000 | 00923 a2200265 4500 | ||
---|---|---|---|
005 | 20250514215406.0 | ||
264 | 0 | _c20050324 | |
008 | 200503s 0 0 eng d | ||
022 | _a0022-1899 | ||
024 | 7 |
_a10.1086/427518 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPhillips, Andrew | |
245 | 0 | 0 |
_aWhen to start therapy. _h[electronic resource] |
260 |
_bThe Journal of infectious diseases _cMar 2005 |
||
300 |
_a821; author reply 821-2 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aLampe, Fiona | |
773 | 0 |
_tThe Journal of infectious diseases _gvol. 191 _gno. 5 _gp. 821; author reply 821-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/427518 _zAvailable from publisher's website |
999 |
_c15365400 _d15365400 |